We are live on ! Find out more
PSTX

Poseida Therapeutics, Inc. Common Stock
PSTX

Delisted

PSTX was delisted on the 7th of January, 2025.

Back to rankings

101 hedge funds and large institutions have $136M invested in Poseida Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 35 increasing their positions, 22 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

507% more call options, than puts

Call options by funds: $182K | Put options by funds: $30K

87% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 15

59% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 22

13% more funds holding

Funds holding: 89 → 101 (+12)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

40% less capital invested

Capital invested by funds: $226M → $136M (-$90.2M)

Holders
101
Holders Change
+12
Holders Change %
+13.48%
% of All Funds
1.61%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
28
Increased
35
Reduced
22
Closed
15
Calls
$182K
Puts
$30K
Net Calls
+$152K
Net Calls Change
-$984K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.87M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.86M
3
SCM
Silverarc Capital Management
Massachusetts
+$2.75M
4
Two Sigma Investments
Two Sigma Investments
New York
+$2.49M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.44M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.39M
2
PBA
Paradigm Biocapital Advisors
New York
-$8.17M
3
Millennium Management
Millennium Management
New York
-$4.02M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$1.62M
5
Invesco
Invesco
Georgia
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
JIC
51
Johnson Investment Counsel
Ohio
$144K – – –
State of Wisconsin Investment Board
52
State of Wisconsin Investment Board
Wisconsin
$134K +$261K +43,579 New
YIH
53
Y-Intercept (HK)
Hong Kong
$133K +$260K +43,321 New
MA
54
MCF Advisors
Kentucky
$132K – – –
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$128K +$248K +41,417 New
CIC
56
Cornercap Investment Counsel
Georgia
$126K -$150K -25,108 -38%
UBS AM
57
UBS AM
Illinois
$120K +$234K +39,000 New
LP
58
LMR Partners
United Kingdom
$117K +$86.3K +14,396 +61%
CS
59
Credit Suisse
Switzerland
$111K +$216K +36,029 New
AQR Capital Management
60
AQR Capital Management
Connecticut
$108K +$211K +35,212 New
VRS
61
Virginia Retirement Systems
Virginia
$107K +$209K +34,900 New
William Blair & Company
62
William Blair & Company
Illinois
$106K +$91.1K +15,200 +79%
DTL
63
Dynamic Technology Lab
Singapore
$104K +$90.5K +15,094 +81%
E
64
Ergoteles
New York
$100K +$195K +32,600 New
Janus Henderson Group
65
Janus Henderson Group
United Kingdom
$99.7K +$194K +32,317 New
Man Group
66
Man Group
United Kingdom
$98K -$166K -27,663 Closed
AI
67
Atom Investors
Texas
$96K -$12.1K -2,015 -6%
CANY
68
Caxton Associates (New York)
New York
$75.8K +$147K +24,608 New
SG Americas Securities
69
SG Americas Securities
New York
$74K +$144K +23,960 New
6CM
70
683 Capital Management
New York
$73.9K -$77.7K -12,966 -35%
VF
71
Virtu Financial
New York
$70K +$30.1K +5,017 +28%
CC
72
Corton Capital
Ontario, Canada
$67.3K +$131K +21,859 New
PCM
73
Penserra Capital Management
California
$62K -$50.2K -8,380 -29%
DC
74
Diametric Capital
Massachusetts
$60.4K +$118K +19,617 New
DU
75
Delphia (USA)
Ontario, Canada
$54.6K +$106K +17,717 New
1 2
3
4 5

PSTX Hedge Fund Activity: Q1 2023 in Review

101 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Poseida Therapeutics, Inc. Common Stock (PSTX) for Q1 2023, worth a combined $136M — down 40% from $226M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new PSTX positions and 15 closed out — a net gain of 13 holders — while 35 added to existing stakes and 22 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $4.87M. The largest seller was Wellington Management Group, cutting an estimated $8.39M.

  • 101 institutional investors held Poseida Therapeutics, Inc. Common Stock (PSTX) as of Q1 2023, up from 89 in Q4 2022.
  • Funds reported $136M of Poseida Therapeutics, Inc. Common Stock stock for Q1 2023, down 40% quarter-over-quarter.
  • 28 funds opened new Poseida Therapeutics, Inc. Common Stock positions in Q1 2023 and 15 closed out, a net change of +13 holders.
  • The largest Poseida Therapeutics, Inc. Common Stock buyer in Q1 2023 was Acadian Asset Management, an estimated $4.87M added.
  • The largest Poseida Therapeutics, Inc. Common Stock seller in Q1 2023 was Wellington Management Group, an estimated $8.39M sold.

Based on aggregated 13F filings for Q1 2023.